Journal of Commercial Biotechnology

Editorial: Finding the Holy Grail in a grain of rice
pp. 173-174(2)
Author: Miller, Henry I

Pitfalls of valuation in biotech
pp. 175-181(7)
Authors: Villiger, Ralph; Bogdan, Boris

The SEC's enforcement programme on biotechnology's communications with the investment community
pp. 182-191(10)
Author: Gabinet, Arthur S

Commercial biotechnology in Latin America: Current opportunities and challenges
pp. 192-199(8)
Author: Quezada, Fernando

Research collaboration and development of intellectual property with the University of Southampton in the field of asthma and COPD
pp. 200-204(5)
Authors: Holgate, Stephen; Edwards, Sue

Bioethical concerns in Japanese biotechnology companies
pp. 205-212(8)
Authors: Kato, Makina; Macer, Darryl

Spin-out fever: Spinning out a University of Oxford company and comments on the process in other universities
pp. 213-219(7)
Author: Savage, Bruce

Winning the game: Public funds for biotech companies
pp. 220-228(9)
Authors: Gollin, Michael; Jack, Eva; Chase, Terry; Soriano, Jesus; Smith, Robert

Strategic alliances as a mechanism for wealth creation in the biopharmaceutical industry: An empirical analysis of the Spanish case
pp. 229-236(8)
Authors: Vázquez, Emma Gutiérrez de Mesa; Martín, Juan Angel Jiménez; Mascareñas, Juan

Autoimmune and inflammatory disorder biologicals will power biotech market growth through to 2010
pp. 237-241(5)
Authors: Churchill, Clare A C; Belsey, Mark J

US and EU legal and regulatory update
pp. 242-252(11)